Results of India’s largest listed healthcare company, Apollo Hospitals, for the fourth quarter of 2024-25 (Q4FY25) were a mixed bag. Revenues for the mainstay hospitals business were impacted by lower patient inflows from Bangladesh while occupancy levels too were lower on a sequential basis.
Given the expansion in bed capacity going ahead, margins are expected to come down, prompting some brokerages to cut their earnings estimates. Despite the pressure on profitability, most analysts are positive on the stock, given strong hospital sales growth going ahead, breakeven in the digital healthcare business (Healthco), and expansion as well as margin gains in

)